Moradabad Educational Trust Group of Institutions
Faculty of Pharmacy

Approved by All India Council for Technical Education & Pharmacy Council of India, New Delhi

Affiliated to Dr. A.P.J. Abdul Kalam Technical University & Board of Technical Education, Lucknow

College Code:598 (AKTU) | College code:1001(BTE)

Moradabad Educational Trust Group of Institutions Faculty of Pharmacy

Approved by AICTE and PCI, New Delhi | Affiliated by AKTU and BTE Lucknow

College Code:598 (AKTU) | College code:1001(BTE)
Admission Helpline Number

8433236242, 9412391802, 6399133001/02/03/04

MIT INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES (MITIJPS)

ISSN 2394-5338 (Print); 2394-5346 (Online)
Volume 7, Issue 2, 2022
This is open access Journal
Global Impact factor:0.565
SJIF Impact factor: 5.296

MITIJPS

Author Guidelines

ONLINE MANUSCRIPT SUBMISSION

An online submission and tracking service via internet facilitates a speedy and cost-effective submission of manuscripts. Manuscripts and the full thematic issues must be submitted online via MIT International Journal of Pharmaceutical Sciences (MITIJPS) Manuscript submission System.

Manuscripts must be submitted by one of the authors of the manuscript and should not be submitted by anyone on their behalf. The principal/corresponding author will be required to submit a Copyright Letter along with the manuscript, on behalf of all the co-authors (if any) to confirm that the manuscript (or any part of it) has not been published previously or is not under consideration for publication elsewhere. Furthermore, any illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. The figures from patent documents are freely available on the databases and may not require any permission unless stated otherwise.

For all online submissions, please provide soft copies of all the materials as main text in MS Word, as well as figures / illustrations in TIFF or JPEG, and chemical structures drawn in ChemDraw (CDX) / as separate files.

It is imperative that before submission, the author(s) should carefully proofread the files for special characters, mathematical symbols, Greek letters, equations, tables, references, and images to ensure that they appear in proper format.
References, figures, tables, chemical structures etc. should be referred to in the text at the appropriate places where they have been first discussed. Figure legends/captions should also be provided.

COPYRIGHT / ARCHIVING POLICIES

Authors who publish in MITIJPS will transfer copyright to their work to MITIJPS Publishers. Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the Copyright Letter or the Terms and Conditions (Download copyright form). It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers when the article is accepted for publication. Once submitted to the journal, the author will not withdraw their manuscript at any stage prior to publication.

Copyright Letter

It is mandatory that a signed copyright letter should also be submitted along with the manuscript by the author to whom correspondence is to be addressed, delineating the scope of the submitted article declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the ‘Instructions for Authors’. All inconsistencies in the text and in the reference section, and any typographical errors must be carefully checked and corrected before the submission of the manuscript. The article should not contain any such material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the copyright agreement. The authors acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the copyright agreement.

MANUSCRIPTS PUBLISHED

The MIT International Journal of Pharmaceutical Sciences will publish original research papers, Short Communications, Reviews (including Minireviews), case report and editorial commentary.

Manuscript Length

Review Articles

The length of a published comprehensive review article is from 4000-8000 words with 50 or more references excluding figures, structures, photographs, schemes, tables, etc.

Mini-Reviews

Mini reviews should be 2000-4000 words with 30 or more references excluding figures, structures, photographs, schemes, tables, etc.

Research Articles

There is no word or page limit for Research articles.

Case Report

There is no word or page limit for case report.

Editorials

Editorials are short papers on important topics related to the journal. The total number of words in an editorial should not exceed 1000 to 1500, and it should contain only 10-15 references. An abstract is not required.

MANUSCRIPTS PUBLISHED

The journal publishes original research, peer-reviewed mini- and full-length review, perspective, and current frontiers, written in English. Single topic/ thematic issues may also be considered for publication.

Manuscript Length

Review Articles

The length of a published comprehensive review article is from 6000-10000 words with 100 or more references excluding figures, structures, photographs, schemes, tables, etc.

Mini-Reviews

Mini-reviews should be 3000- 6000 words with 75 or more references excluding figures, structures, photographs, schemes, tables, etc.

Research Articles

Research articles should be of 4000-6000 words with 75 or more references excluding figures, structures, photographs, schemes, tables, etc.

Letters to the Editor

The journal will also consider for publication letters that comment on original work and reviews published in Recent Patents on Nanotechnology. It is recommended that these letters usually not exceed 800 words plus up to 10 references. Longer letters are less likely to be published. However, the Editors recognize that in some cases letters may need to be longer. All letters should be submitted to the journal Editor-in-Chief. Authors/readers are encouraged to comment/ debate/ challenge any of the published articles of this journal.

Editorials

Editorials are short papers on important topics related to the journal. The total number of words in an editorial should not exceed 1000 to 1500, and it should contain only 10-15 references. An abstract is not required.

MANUSCRIPT PREPARATION

The manuscript should be written in English in a clear, direct and active style. All pages must be numbered sequentially, facilitating in the reviewing and editing of the manuscript.

Microsoft Word Template

It is advisable that authors prepare their manuscript using the template available on the Web, which will assist in preparation of the manuscript according to journal’s format (Download the MS Template)

Sections in Manuscripts

Manuscripts submitted for research and review articles in the journal should be divided into the following sections:

  • Title
  • Title Page
  • Structured Abstract
  • Graphical Abstract
  • Keywords
  • Text Organization
  • Current & Future Developments
  • List of Abbreviations (if any)
  • Acknowledgements
  • Conflict of Interest
  • References
  • Appendices
  • Figures/Illustrations (if any)
  • Chemical Structures (if any)
  • Tables (if any)
  • Supportive/Supplementary Material (if any)

Title

The title of the article should be precise and brief and must not be more than 120 characters. Authors should avoid the use of non-standard abbreviations and question marks in titles. The first letter of each word should be in capital letters except for articles, conjunctions and prepositions.

Authors should also provide a short ‘running title’ with no more than 80 characters. Title, running title, by line correspondent foot note & keywords should be written as presented in original manuscript.

Title Page

Title page should include paper title, author(s) full name and affiliation, corresponding author(s) names complete affiliation/address, along with phone, fax and email.

Short Running Title

Authors must provide a short ‘running title’ of their manuscript.

Structured Abstract

The abstract of an article should be its clear, concise and accurate summary, having no more than 250 words, and including the explicit sub-headings (as in-line or run-in headings in bold). Use of abbreviations should be avoided, and the references should not be cited in the abstract.

All the original research articles must be accompanied with a structured abstract. Ideally, each abstract should include the following sub-headings, but these may vary according to requirements of the article.

Background

Objective

Methods

Results

Conclusion

The headings can vary, but must state the purpose of the study, details of the participants, measurements, methods, main findings and conclusion.

Graphical Abstract

A graphic should be included, when possible, with each manuscript for use in the Table of Contents (TOC). This must be submitted separately as an electronic file (preferred file types are TIFF, and PowerPoint). A graphical abstract, not exceeding 30 words along with the illustration, helps to summarize the contents of the manuscript in a concise pictorial form. It is meant as an aid for the rapid viewing of the journals’ contents and to help capture the readers’ attention. The graphical abstract may feature a key structure, reaction, equation, etc. that the manuscript elucidates upon.

Graphical Abstracts should be submitted as a separate file (must clearly mention graphical abstract within the file) online via MIT International Journal of Pharmaceutical Sciences Manuscript Submission System.

Keywords

6 to 8 keywords must be provided. Choose important and relevant keywords that researchers in your field will be searching for so that your paper will appear in a database search. The keywords should be contained in the title, and they should appear several times in the article.

Text Organization

The main text should begin on a separate page and should be divided into title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed, which should be followed by the List of Abbreviations, Current & Future Developments, Conflict of Interest, Acknowledgements and Reference sections. For review, the manuscript should be divided into title page, abstract and the main text. The Review Article should mention any previous important recent and old reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments. The authors should avoid presenting material which has already been published in a previous review. The authors are advised to present and discuss their observations in brief.

For Research Articles the manuscript should begin with the title page and abstract followed by the main text, which must be structured into separate sections as Introduction, Materials and Methods, Results, Discussion, Conclusion, Conflict of Interest, Acknowledgements and References.

The manuscript style must be uniform throughout the text and 10 pt Times New Roman font should be used. The full term for an abbreviation should precede its first appearance in the text unless it is a standard unit of measurement. The reference numbers should be given in square brackets in the text. Italics should be used for Binomial names of organisms (Genus and Species), for emphasis and for unfamiliar words or phrases. Non-assimilated words from Latin or other languages should also be italicized e.g. per se, et al. etc.

Section Headings

Section headings should be numbered sequentially, left aligned and have the first letter capitalized, starting with the introduction. Sub-section headings, however, should be in lower-case and italicized with their initials capitalized. They should be numbered as 1.1, 1.2, etc.

Introduction

The Introduction section should include the background and aims of the research in a comprehensive manner.

Materials And Methods

This section provides details of the methodology used along with information on any previous efforts with corresponding references. Any details for further modifications and research should be included. Sufficient details should be provided to the reader about the original data source in order to enable the analysis, appropriateness and verification of the results reported in the study.

It is important for the Method Section should be sufficiently detailed in respect of the data presented, and the results produced from it. This section should include all the information and protocol gathered for the study at the time when it was being written. If the study is funded or financially supported by an organization to conduct the research, then it should be mentioned in the Method Section. Methods must be result-oriented.

Experimental

Repeated information should not be reported in the text of an article. A calculation section must include experimental data, facts and practical development from a theoretical perspective.

Results

The important and main findings of the study should come first in the Results Section. The tables, figures and references should be given in sequence to emphasize the important information or observations related to the research. The repetition of data in tables and figures should be avoided. Results should be precise.

Discussion

This should explore the significance of the results of the work, present a reproducible procedure and emphasis the importance of the article in the light of recent developments in the field. Extensive citations and discussion of published literature should be avoided.

The Results and Discussion may be presented together under one heading of “Results and Discussion”. Alternatively, they may be presented under two separate sections (“Results” section and “Discussion” Sections). Short sub- headings may be added in each section if required.

Conclusion

A small paragraph summarizing the contents of the article, presenting the final outcome of the research or proposing further study on the subject, may be given at the end of the article under the Conclusion section.

Funding

The authors need to declare the funding sources of their manuscripts clearly by providing the name of the funding agency or financial support along with allotted grant/award number in round brackets (if applied), for instance, “This work was financially supported by [Name of the funding agency] (Grant number XXX)”.

Similarly, if a paper does not have any specific funding source, and is part of the employment of the authors, then the name of the employer will be required. Authors will have to clearly state that the funder was involved in writing, editing, approval, or decision to publish the article.

Ethical Approval of Studies and Informed Consent

For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee and should be documented in your paper. For investigations undertaken on human subjects, state in the Methods section the manner in which the informed consent was obtained from the study participants (i.e., oral or written), where there is an unavoidable risk of breach of privacy- e.g., in a clinical photograph or in case details- the patient’s written consent or that of the next of kin, to publication must be obtained. We will ask you to send a signed consent form before publication. Consent must be obtained for all Case Reports and Clinical Pictures.

Current & Future Developments

The review article should conclude with a short section called “Current & Future Developments”. The author(s) will give their opinion on the current and future important developments on the topic discussed in their article.

List of Abbreviations (If Any)

If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided.

RESEARCH ETHICS AND POLICIES

Conflict Of Interest

Authors

All potential conflicts of interest (competing interests) that could have a direct or indirect influence on the work must be disclosed by the authors. Even if an author does not have a conflict, disclosing affiliations and interests allows for a more comprehensive and open approach, which leads to a more accurate and objective evaluation of the work. Conflicts of interest, whether genuine or imagined, are a perspective to which the readers are entitled.

The publication of a conflict statement in the article itself, as well as the submission of the conflict disclosure form, is required for all types of papers. It is not necessarily the case that a monetary relationship with examination support or funding for counseling work is inappropriate. Even if the authors do not have any conflict of interest, they still need to provide a confirmation statement in their manuscripts, i.e., “The author(s) confirm(s) that there is no conflict of interest related to the manuscript.”

Peer Reviewers

MITIJPS tries to conduct a transparent peer-review process with the help of the reviewers who do not have any conflict of interest with the authors. In this connection, reviewers who belong to the same institute or countries as authors are not invited to review manuscripts. However, it is not possible for the Editorial Office to be aware of all competing interests; therefore, it is expected from authors to submit:

List of reviewers who they think have a conflict of interest to ensure a transparent and unbiased review process.

The Editorial Office expects reviewers:

Not to accept manuscript review requests if they have any potential conflict of interest and inform the Editorial Office accordingly.

To decline review requests if they have recently published or submitted an article with any of the authors listed in the manuscript.

To inform the Editorial Office if they have any personal relationship with the authors or work in the same institutes as of authors, which could affect the review transparency.

To abstain from reviewing and informing the Editorial Office/Editor-in-Chief/Handling Editors about any scientific misconduct or fraud, plagiarism, conflict of interest, or any other unethical behavior related to the manuscript, which they found while reviewing it.

During the submission of review comments, reviewers are asked to reconfirm that they do not have any conflict of interest related to the article. After confirming the below statement, they can submit their comments.

“I hereby confirm that I don’t have any conflict of interest related to the manuscript.”

If, however, there are still any remaining interests, then reviewers must mention those in the ‘Confidential’ section of the review form.

Reviewers are not encouraged to contact authors directly regarding any of their conflicts of interest. Peer reviewers should follow journals’ policies in situations they consider representing a conflict to reviewing.

Undisclosed Conflict of Interest

If reviewers intentionally undisclosed any conflict of interest, then they will be blacklisted for any future peer reviewing activity of the journal.

The Editorial Office always ensures that an author, if added after peer review activity of a manuscript, is not part of the reviewers’ list who have conducted a peer review of the same manuscript.

Editors

Editors must not review submitted manuscripts if they have any personal, professional or financial involvement/conflict of interest with the authors of the manuscript. Every participant involved in the peer review process, including editorial board members, reviewers, and editors, must declare any potential conflicts of interest to ensure a transparent and unbiased review activity.

Editors-in-Chief or Editors who are responsible for the initial and final decision should recuse themselves to review or take decisions on any manuscript that is written by authors affiliated to the same institute as of editor, or if they have been a family member, competitor, collaborator, or have published any manuscript in last 3 years with the authors associated with the manuscript. They can however nominate someone else on the Board who could provide a neutral opinion on the manuscript.
The Editorial office recommends editors to follow COPE and WAME guidelines to process such manuscripts which involves their personal relationship.

Manuscripts submission by an Editor/Editor-in-Chief

The initial and final decision on the manuscripts submitted by an Editor/Editor-in-Chief will be taken by any other member of the Board. The Editorial Office will identify members who do not have any potential conflict of interest with the Editor or Editor-in-Chief.

Acknowledgements

Financial contributions to the work being reported should be clearly acknowledged. Please acknowledge anyone (individual/company/institution) who has contributed to the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgement section.

Consent for Publication

If the manuscript has an individuals’ data, such as personal detail, audio-video material etc., consent should be obtained from that individual. In case of children, consent should be obtained from the parent or the legal guardian.

All such case reports should be followed by a proper consent prior to publishing.

REFERENCES

References should be submitted preferably in the Vancouver style. All references must be complete and accurate. The reference numbers must be finalized, and the bibliography must be fully formatted before submission.

The references should be relevant to the study and should refer to the original research sources. Self-citation and self-interest should be avoided by the authors, editors and peer-reviewers.

Vancouver Style

In Vancouver style, all references should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section. Punctuation should be properly applied as mentioned in the examples given above.

Reference Lists

Different reference formats have different rules for citation. See below for some common format examples.

Journal Article

The required information for a journal article is author, abbreviated journal title, year, publication, volume number, and initial page of cited article, though complete pagination is possible. It is necessary to list all authors if the total number of author is six or less and for more than six authors use three authors and then et al (the term “et al.” should be in italics). Journal abbreviations should follow the Index Medicus/MEDLINE. Capitalize the first letter of the first word in the title. The rest of the title is in lower-case, with the exception of proper names.

[1] Al-Habian A, Harikumar PE, Stocker CJ, Langlands K, Selway JL. Histochemical and immunohistochemical evaluation of mouse skin histology: comparison of fixation with neutral buffered formalin and alcoholic formalin. J Histotechnol. 2014 Dec;37(4):115-24.

[2] Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006 May 11;354(19):1985-1997.

Edited Book

[3] Blaxter PS, Farnsworth TP. Social health and class inequalities. In: Carter C, Peel JR, Eds. Equalities and inequalities in health. 2nd ed. London: Academic Press 1976; pp. 165-78.

Chapter in a Book

[4] Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, Eds. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press 1995; pp. 465-78.

Patent

[5] Larsen CE, Trip R, Johnson CR. Methods for procedures related to the electrophysiology of the heart. US Patent 5529067, 1995.

Conference Proceedings

[6] Kimura J, Shibasaki H, Eds. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier 1996.

Thesis and Dissertation

[7] Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans. PhD dissertation. Mount Pleasant (MI): Central Micihigan University 2002.

URL(WebPage)

[8] Aylin P, Bottle A, Jarman B, Elliott, P. Paediatric cardiac surgical mortality in England after Bristol: descriptive analysis of hospital episode statistics 1991-2002. BMJ [serial on the Internet]. 2004 Oct 9; [cited: 15 October 2004]; 329: [about 10 screens]. Available from: sis.nlm.nih.gov/Tox/ToxMain.html

Electronic Material

Journal Article in Electronic Format

[9] Frangioni G, Bianchi S, Fuzzi G, Borgioli G. Dynamics of hepatic melanogenesis in newts in recovery phase from hypoxia. Open Zoo J 2009; 2: 1-7. Available from: https://benthamopen.com/ABSTRACT/TOZJ-2-1 [cited: 26th Jan 2009]

[10] Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. June 2002 [cited: 12th Aug 2002]; 102(6): [about 3 p.]. Available from: www.nursingworld.org/AJN/2002/june/Wawatch.htm.

FIGURES / TABLES

Figures/Illustrations (if any)

The authors are expected to submit good quality figure(s) in PDF, PPT, MS Word, TIFF or JPEG versions, which, if required, should be improved yourself.

Scaling/Resolution

Line Art image type is normally an image based on lines and text. It does not contain tonal or shaded areas. The preferred file format should be TIFF or EPS, with the color mode being Monochrome 1-bit or RGB, in a resolution of 900-1200 dpi.

Halftone image type is a continuous tone photograph containing no text. It should have the preferred file format TIFF, with color mode being RGB or Grayscale, in a resolution of 300 dpi.

Combination image type is an image containing halftone , text or line art elements. It should have the preferred file format TIFF, with color mode being RGB or Grayscale, in a resolution of 500-900 dpi.

Guideline for Figures/Illustrations

Illustrations must be provided according to the following guideline:

  • Illustrations should be embedded in the text file and must be numbered consecutively in the order of their appearance. Each figure should include only a single illustration which should be cropped to minimize the amount of space occupied by the illustration.
  • If a figure is in separate parts, all parts of the figure must be provided in a single composite illustration file.
  • Photographs should be provided with a scale bar if appropriate, as well as high-resolution component files.
  • All the numbers, symbols, and letters in figures should be consistent and clear throughout and large enough to remain readable when the size is reduced for publication.
  • It must be ensured to cite each figure in the text in sequence.

AUTHORSHIP

Authorship Criteria

MITIJPS requires that all individuals listed as authors must have made a substantial contribution to the design, performance, analysis, or reporting of the work.

Authors and Institutional Affiliations

Authors must provide a final list of authors at the time of submission, ensuring the correct sequence of the names of authors, which will not be considered for any addition, deletion or rearrangement after final submission of the manuscript. The email address of the principal author should be provided with an asterisk. However, the complete address, business telephone numbers, fax numbers and e-mail address of the corresponding author must be stated to receive correspondence and galley proofs.

Changes to Authorship

At the time of initial submission, the finalized list of authors in correct sequence should be provided, which will not be changed once the publication process has started.

If any change is essential, then it can only be done after the approval of the Editor-in-Chief upon receiving the following details from the corresponding author:

  1. The reason for the change in the author list and/or their sequence
    • A proper justification should be provided for changes in authorship.
    • Correction of existing names should be accompanied by a notice to the Editor-in-Chief of the journal.
  2. A written confirmation from all the co-authors is a prerequisite for any amendment or removal.

Any amendment to the authors’ list will only be considered and approved by the Editor-in-Chief after complete verification. Publication of the manuscript will be withheld during consideration of the request. However, if the manuscript has already been published online, requests approved thereafter by the Editor-in-Chief will result in an erratum or corrigendum. The corresponding author is responsible for obtaining permission from all co-authors for any changes in the authorship.

LANGUAGE AND EDITING

Manuscripts containing language inconsistencies will not be published. Authors should seek professional assistance for correction of grammatical, scientific, and typographical errors before submission of the revised version of the article for publication.

Proofs Corrections

Authors will receive page proofs of their accepted paper before publications. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Major changes are not acceptable at the proof stage. If unable to send corrections within 48 hours due to some reason, the author(s) must at least send an acknowledgement on receiving the galley proofs or the article will be published exactly as received and the publishers will not be responsible for any error occurring in the published manuscript in this regard.

The corresponding author will be solely responsible for ensuring that the revised version of the manuscript incorporating all the submitted corrections receives the approval of all the co-authors of the manuscript.

PAGE CHARGES/PUBLICATION FEE

No page charges/Publication fees will be charge for the publication of Articles.

PLAGIARISM PREVENTION

MIT International Journal of Pharmaceutical Sciences (MITIJPS) uses the Turnitin software which detects instances of overlapping and similar text in submitted manuscripts. This software checks content against a database of periodicals, the Internet, and a comprehensive article database. It generates a similarity report, highlighting the percentage overlap between the uploaded article and the published material. Any instance of content overlap is further scrutinized for suspected plagiarism according to the publisher’s Editorial Policies. If the similarity seems legitimate, the article will be proceeded for further review process; however, in cases of superfluous plagiarism, the authors have to revise the text as per editorial instructions.

Low Text Similarity

The text of every submitted manuscript is checked by using Turnitin. The Content Tracking mode ensures that manuscripts with an overall low percentage similarity (but which may have a higher similarity from a single source) are not overlooked. If the similarity level is significantly high, then the manuscript is returned to the author for paraphrasing the text and citing the original source of the copied material.

It is important to mention that the text taken from different sources with an overall low similarity percentage will be considered as a plagiarized content if the majority of the article is a combination of copied material.

High Text Similarity

There may be some manuscripts with an overall low similarity percentage, but a higher percentage from a single source. For instance, a manuscript may have less than 20% overall similarity but there may be 15 % similar text taken from a single article; the similarity index in such cases is higher than the approved limit for a single source. Authors are advised to thoroughly rephrase the similar text and properly cite the original source to avoid plagiarism and copyright violation.

Plagiarism in Published Manuscripts

Published manuscripts which are found to contain plagiarized text are retracted from the journal website after careful investigation and approval by the Editor-in-Chief of the journal. A ‘Retraction Note’ as well as a link to the original article is published on the electronic version of the plagiarized manuscript and an addendum with retraction notification in the journal concerned.